共 371 条
[1]
Hundahl SA(1998)A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995 Cancer 83 2638-2648
[2]
Fleming ID(2010)Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system Thyroid 20 1341-1349
[3]
Fremgen AM(2011)Delayed risk stratification, to include the response to initial treatment (surgery and radioiodine ablation), has better outcome predictivity in differentiated thyroid cancer patients Eur. J. Endocrinol. 165 441-446
[4]
Menck HR(2015)Implementing the modified 2009 American Thyroid Association risk stratification system in thyroid cancer patients with low and intermediate risk of recurrence Thyroid 25 1235-1242
[5]
Tuttle RM(2015)American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer Thyroid 26 1-133
[6]
Tala H(2012)Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement? J. Clin. Endocrinol. Metab. 97 2748-2753
[7]
Shah J(2016)Serial post-surgical stimulated and unstimulated highly sensitive thyroglobulin measurements in low and intermediate-risk papillary thyroid carcinoma patients not receiving radioactive iodine Endocrine 54 460-466
[8]
Leboeuf R(2002)Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation Clin. Endocrinol. 57 215-221
[9]
Ghossein R(1995)Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? J. Clin. Endocrinol. Metab. 80 468-472
[10]
Gonen M(2005)Clinical impact of thyroglobulin (Tg) and Tg autoantibody method differences on the management of patients with differentiated thyroid carcinomas J. Clin. Endocrinol. Metab. 90 5566-5575